Pelthos Therapeutics Inc. (PTHS) Operating cash flow 2022–2025
Pelthos Therapeutics Inc. (PTHS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$22.6MFY2025 · since FY2022: -$1.6M → -$22.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$22.6M | -290.0% |
| FY2024 | -$5.8M | -490.4% |
| FY2023 | -$981,031 | +37.4% |
| FY2022 | -$1.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PTHS financial trends
PTHS RevenuePTHS Net incomePTHS Net marginPTHS Gross profitPTHS Gross marginPTHS Operating incomePTHS Operating marginPTHS Free cash flowPTHS Capital expendituresPTHS Return on equityPTHS Stock buybacksPTHS Dividends paidPTHS Total assetsPTHS Total liabilitiesPTHS Shareholders’ equityPTHS overview →